4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
NUTRITIONAL ANEMIA
Nutritional Anemia
Dr. Bharat R. Agarwal
Pediatric Hematologist-Oncologist, Division of Pediatric Hem-Onco,
B.J. Wadia Hospital for Children


MANAGEMENT :

Management of iron deficiency anemia can be considered in the two parts:
  • Treatment of individual patient.
  • Treatment of IDA - public health problem.

Treatment of individual patient :

Management of individual patient consists of:
  • Replenishment of reduced body iron
  • Correction of underlying factors responsible for the deficiency. In 80-85 % of patients, it is possible to determine the causes of deficiency.

Successful management requires :
  • Confirmation of diagnosis,
  • Through investigation of the underlying cause,
  • Supplementation of iron.

It is important to find out the cause of iron deficiency. In children, it is often due to poor intake rather than blood loss. Therefore, the key to success in the management of IDA is proper nutritional counseling. Parents should be made to understand the need for a well balanced diet, particularly in growing children. Continuation of breast milk should be encouraged beyond 6 months, as bioavailability of iron in the breast milk is high. Restriction of milk to one pint a day, and introduction of iron rich weaning foods like nachani, jaggery, cereals, spinach, beans, meat, fruits etc. and iron fortified food should be advocated.

A) Oral iron therapy : This is the treatment of choice, as it is cheap, safe, effective and well tolerated. Parenteral administration is reserved for patient who are completely intolerant to oral iron or when compliance is poor. Various preparations available are shown in Table 5.

Ferrous salts are absorbed better than ferric salts. Of the ferrous salts, ferrous sulphate is most preferred because of its low cost.

Various types of preparation available are as follows :

Table 5: PERCENTAGE & AMOUNT OF IRON IN SOME COMMONLY USED IRON TABLETS

Preparation Iron compound
(mg) per tab
Elemental iron
(mg) per tab
% of iron given
Ferrous fumarate 200 66 33
Ferrous gluconate 300 36 12
Ferrous sulphate
(7H 2 O)
300 60 20
Ferrous sulphate
(anhydrous)
200 74 37

  • Uncoated tablets and sugar coated tablets : Least expensive but less effective as they get oxidized.

  • Enteric coated tablets : More expensive, disintegrate only partially in gastric acidity. Side effect are minimal, therefore better compliance. However, if disintegration of the tablet does not take place, than it may not be effective.

  • Liquid preparations : They include syrups and drops. Useful for children and infants but are expensive and deteriorate on storage.

  • Combination of other nutrients : Ascorbic acid in the dose of 100mg/15mg elemental iron enhances absorption of 30%. But it is expensive and increases side effects.

    Dose/ duration : 4-6 mg/ kg/day of elemental iron is started and continued for three months after Hb returns to the normal so as to also replenish the deficiency of storage. For children effective dosage is 1.5-2.0 mg. of elemental iron/kg/body weight 3 times per day.

    Difficulty encountered with oral iron : Sub-optimal response may be due to
    • Poor compliance
    • reparation with poor content and absorption of iron
    • Malabsorption
    • Loss greater than intake as seen in telangiectasia, portal hypertension, piles etc.
    • Discontinuation of treatment after initial 3 - 4 weeks because of a feeling of well-being or due to gastrointestinal adverse side-effects
    • Concurrent protein, folic acid, B12 or other nutrients deficiencies
    • Incorrect diagnosis

    Response to Treatment : A positive response to treatment can be defined as a daily increase in Hemoglobin concentration of 0.1 - 0.3 g/dl or 1% rise in Hematocrit daily from fourth day onwards. Reticulocytes increase within 3 to 5 days of initiation of treatment, reaching a peak at 7 - 10 days. Hemoglobin is virtually normalized after two months of therapy. With onset of treatment, patient shows rapid subjective improvement with disappearance of fatigability, lassitude, pica and other non-specific symptoms even before there is increase in hemoglobin level.

    Side Effects : Side effects are probably related to dose and amount of elemental iron. They include gastrointestinal symptoms - heart burn, nausea, abdominal cramps, diarrhea, constipation, blackish discoloration of tongue and teeth etc.

B) Parenteral Iron Therapy :

This mode of administration should be resorted to only in cases where anemia persists due to the factors causing failure of oral iron therapy like
  • Intolerance to oral iron therapy
  • Non-compliance
  • Loss of iron at a rate too rapid for the oral intake to compensate for the loss (e.g. hereditary hemorrhagic telangiectasia)
  • Disorders of GI tract like ulcerative colitis, malabsorption,
  • unable to maintain iron balance on treatment or hemodialysis
  • Donating large amounts of blood for autotransfusion programme.

It includes both intramuscular and intravenous iron therapy. The preparation most popularly used is iron dextran, which contains 50 mg/ml of elemental iron.

Intramuscular iron administration : It is very painful and may cause serious allergic reactions. Hence, it is not used in children. IM injections are best given deep into the upper outer quadrant of gluteal region and skin should be laterally displaced before injection (Z tract technique) to prevent iron staining of the skin. A dose of 0.25 cc should be given as a test dose IM, and if there are no reactions after 1 hour, then full dose can be given.

Intravenous iron therapy :
  • Infusion of iron dextran (diluted in ratio of 5 ml iron dextran complex in 100 ml of saline solution). Initially flow rate should be kept at 20 drops per minute for 5 minutes, if there are no side effects, then the rate may be increased to 40 - 60 drops per minute.
  • Bolus iron dextran (diluted in a small volume).

Both are however given only after a prior sensitivity testing with intravenous test dose injection. Infusion therapy is associated with a higher incidence of adverse effects as compared to bolus treatment. Nevertheless, both forms of treatment are not spared from anaphylactic reactions. This must be taken as a word of caution against use of intravenous iron therapy.

 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us